-Michael P Busch Researcher Activity Profile

Research Author Detailed Information 

Michael P Busch Publication Rate By Year

Michael P Busch has published 4 paper(s) in 2006, 11 paper(s) in 2007, 10 paper(s) in 2008, for a total of 25 research publications in total.

Michael P Mp Busch Author Information

LAST NAME: busch

FIRST NAME: Michael P

INITIALS: mp

AFFILIATION:

Papers

Michael P Busch's Publication Record

1. Leukoreduction of blood transfusions does not diminish transfusion-associated microchimerism in trauma patients. Year Published: 2006
Department of Surgery, Harborview Medical Center/University of Washington, Seattle, Washington, USA. garth.utter@ucdmc.ucdavis.edu
2. Enhanced ascertainment of microchimerism with real-time quantitative polymerase chain reaction amplification of insertion-deletion polymorphisms. Year Published: 2006
Blood Systems Research Institute, San Francisco, California 94118, USA. tlee@bloodsystems.org
3. Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes. Year Published: 2006
Division of Viral Products, Center for Biologics Evaluation and Research, FDA, Bethesda, MD 20892, USA.
4. Antibodies to a novel antigen in acute hepatitis C virus infections. Year Published: 2006
Blood Systems Research Institute, San Francisco, CA, USA. ltobler@bloodsystems.org
5. Transfusion-associated microchimerism: a new complication of blood transfusions in severely injured patients. Year Published: 2007
Blood Systems Research Institute, San Francisco, CA 94118, USA. wreed@bloodsystems.org
6. Phylogenetic analysis of WNV in North American blood donors during the 2003-2004 epidemic seasons. Year Published: 2007
Blood Systems Research Institute, San Francisco, CA 94118, USA.
7. Flavivirus serology by Western blot analysis. Year Published: 2007
California Department of Health Services, Viral and Rickettsial Disease Laboratory, Richmond, California 94804, USA.
8. Performance of a transcription-mediated-amplification HIV-1 RNA assay in pooled specimens. Year Published: 2007
Division of Infectious Diseases, University of California-San Francisco, San Francisco, CA, United States.
9. Persistence of West Nile virus-specific antibodies in viremic blood donors. Year Published: 2007
Focus Diagnostics, Cypress, California, USA. hprince@focusdx.com
10. Transfusion-associated microchimerism. Year Published: 2007
Department of Surgery, UC, Davis Medical Center, Sacramento, CA 95817, USA. garth.utter@ucdmc.ucdavis.edu
11. Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000. Year Published: 2007
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
12. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Year Published: 2007
Westat, 1650 Research Boulevard, Rockville, MD 20850, USA.
13. Distinguishing acute from chronic and resolved hepatitis C virus (HCV) infections by measurement of anti-HCV immunoglobulin G avidity index. Year Published: 2007
Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
14. Performance of a transcription-mediated-amplification HIV-1 RNA assay in pooled specimens. Year Published: 2007
Division of Infectious Diseases, University of California-San Francisco, San Francisco, CA, United States.
15. Persistence of West Nile virus-specific antibodies in viremic blood donors. Year Published: 2007
Focus Diagnostics, Cypress, California, USA. hprince@focusdx.com
16. The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy. Year Published: 2008
Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
17. Reply. Year Published: 2008
Division of Transfusion Medicine, University of Cambridge, Cambridge, UK.
18. Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations. Year Published: 2008
From Biomedical Services, Medical Office, American Red Cross, Washington, DC, USA.
19. Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. Year Published: 2008
Blood Systems Research Institute, 270 Masonic Ave., San Francisco, CA 94118. Mbusch@bloodsystems.org.
20. Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression. Year Published: 2008
Box 0560, Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 94143, USA. peter@biostat.ucsf.edu
21. Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. Year Published: 2008
University of California, San Francisco, California, USA.
22. The TNF (-308A) polymorphism is associated with microchimerism in transfused trauma patients. Year Published: 2008
23. Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations. Year Published: 2008
Biomedical Services, Medical Office, American Red Cross, Washington, DC 20006, USA. BenjaminR@usa.redcross.org
24. Biobanks of blood from donors and recipients of blood products. Year Published: 2008
Sanquin Consulting Services, P.O. Box 9137, NL-1006 AC, Amsterdam, The Netherlands. h.reesink@sanquin.nl
25. The TNF (-308A) polymorphism is associated with microchimerism in transfused trauma patients. Year Published: 2008
Department of Laboratory Medicine, University of California, San Francisco, USA.